Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases
Drug Discoveries & Therapeutics · 2023
DOI: 10.5582/ddt.2023.01022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Discoveries & Therapeutics, 2023. Verfasst von Meirong Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Municipal Hospital, Qingdao, China. Hauptthemen laut MEDLINE: COVID-19, Hepatitis, Autoimmune. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) vaccines have been shown to be effective in protecting people from severe disease progression, hospitalisation and death. However, a wide range of side effects have been reported worldwide. New onset or flare-up of autoimmune hepatitis (AIH) is an extremely rare adverse event following COVID-19 vaccination, with the majority of cases presenting with mild symptoms. Unfortunately, there have been cases of fatal complications. In this mini-review, we have summarised the clinical characteristics of a total of 35 currently reported cases of AIH after COVID-19 vaccination and suggest that patients with autoimmune diseases may be at higher risk of developing AIH after vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qingdao Municipal Hospital, Qingdao, China.
- Qingdao Women and Children's Hospital, Qingdao, China.
Zitieren
APA
Wang, M., Qi, J., & Liu, Y. (2023). Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2023.01022
Vancouver
Wang M, Qi J, Liu Y. Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases. Drug Discoveries & Therapeutics. 2023. doi:10.5582/ddt.2023.01022
BibTeX
@article{Wang2023,
author = {Wang, Meirong and Qi, Juan and Liu, Yujuan},
title = {Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases},
journal = {Drug Discoveries & Therapeutics},
year = {2023},
doi = {10.5582/ddt.2023.01022}
}
EUVIMED